Across TCGA pan-cancer cohorts, SNX18P27 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SNX18P27’s most consistent transcriptional readouts.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where SNX18P27 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNX18P27 is over-expressed in tumor.
UCEC and LIHC are the cancer types where SNX18P27 tumor–normal differential expression is most reproducible.